Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on December 20, 2004

Circulation. 2004
Published online before print December 20, 2004, doi: 10.1161/01.CIR.0000151516.84238.37
A more recent version of this article appeared on January 4, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/1/51    most recent
01.CIR.0000151516.84238.37v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahokas, R. A.
Right arrow Articles by Weber, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahokas, R. A.
Right arrow Articles by Weber, K. T.
Related Collections
Right arrow Animal models of human disease
Right arrow Heart failure - basic studies
Right arrow Oxidant stress

Submitted on August 5, 2004
Revised on September 10, 2004
Accepted on September 29, 2004

Aldosteronism and a Proinflammatory Vascular Phenotype. Role of Mg2+, Ca2+, and H2O2 in Peripheral Blood Mononuclear Cells

Robert A. Ahokas PhD, Yao Sun MD, PhD, Syamal K. Bhattacharya PhD, Ivan C. Gerling PhD, and Karl T. Weber MD*

From the Departments of Obstetrics and Gynecology (R.A.A.), Surgery (S.K.B.), and Divisions of Cardiovascular Diseases (Y.S., K.T.W.) and Endocrinology and Metabolism (I.C.G.), Department of Medicine, University of Tennessee Health Science Center, Memphis, Tenn.

* To whom correspondence should be addressed. E-mail: KTWeber{at}utmem.edu.

Background--Chronic, inappropriate (relative to dietary Na+) elevations in circulating aldosterone, such as occur in congestive heart failure, are accompanied by a proinflammatory vascular phenotype involving the coronary and systemic vasculature. An immunostimulatory state with activated peripheral blood mononuclear cells (PBMCs) precedes this phenotype and is induced by a fall in cytosolic free [Mg2+]i and subsequent Ca2+ loading of these cells and transduced by oxidative/nitrosative stress.

Methods and Results--We sought to further validate this hypothesis in rats with aldosterone/1%NaCl treatment (ALDOST) by using several interventions as cotreatment: a Mg2+-supplemented diet; amlodipine, a CCB; and N-acetylcysteine, an antioxidant. Blood samples were obtained at weeks 1 to 4 of ALDOST to monitor [Mg2+]i, [Ca2+]I, and H2O2 production in PBMCs. Coronal ventricular sections were examined for invading inflammatory cells and 3-nitrotyrosine labeling, a marker of oxidative/nitrosative stress. In response to ALDOST and compared with untreated controls, we found an early and persistent reduction in [Mg2+]i with a subsequent rise in [Ca2+]i and H2O2 production, each of which was either attenuated or abrogated by the Mg2+-supplemented diet and by N-acetylcysteine, whereas amlodipine prevented Ca2+ loading and an altered redox state. Cotreatment with these interventions either markedly attenuated or prevented the appearance of the proinflammatory coronary vascular phenotype and the presence of 3-nitrotyrosine in invading inflammatory cells.

Conclusions--We suggest that the immunostimulatory state that appears during aldosteronism and leads to a proinflammatory coronary vascular phenotype is induced by a fall in [Mg2+]i with Ca2+ loading of PBMCs and is transduced by H2O2 production in these cells.


Key words: calcium • stress • pathology • aldosterone • magnesium




This article has been cited by other articles:


Home page
Eur Heart JHome page
S. Klotz, D. Burkhoff, I. M. Garrelds, F. Boomsma, and A.H.J. Danser
The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
Eur. Heart J., April 1, 2009; 30(7): 805 - 812.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. Tastan, R. Schreckenberg, S. Mufti, Y. Abdallah, H. M. Piper, and K.-D. Schluter
Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way
Cardiovasc Res, April 1, 2009; 82(1): 77 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. A. Maron, Y.-Y. Zhang, D. E. Handy, A. Beuve, S.-S. Tang, J. Loscalzo, and J. A. Leopold
Aldosterone Increases Oxidant Stress to Impair Guanylyl Cyclase Activity by Cysteinyl Thiol Oxidation in Vascular Smooth Muscle Cells
J. Biol. Chem., March 20, 2009; 284(12): 7665 - 7672.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. T. Weber, W. B. Weglicki, and R. U. Simpson
Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium
Cardiovasc Res, February 15, 2009; 81(3): 500 - 508.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Sontia, A. C.I. Montezano, T. Paravicini, F. Tabet, and R. M. Touyz
Downregulation of Renal TRPM7 and Increased Inflammation and Fibrosis in Aldosterone-Infused Mice: Effects of Magnesium
Hypertension, April 1, 2008; 51(4): 915 - 921.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. P. Shapiro, T. E. Owan, S. Mohammed, M. Kruger, W. A. Linke, J. C. Burnett Jr, and M. M. Redfield
Mineralocorticoid Signaling in Transition to Heart Failure With Normal Ejection Fraction
Hypertension, February 1, 2008; 51(2): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. J. Brown
Aldosterone and Vascular Inflammation
Hypertension, February 1, 2008; 51(2): 161 - 167.
[Full Text] [PDF]


Home page
Clin Med ResHome page
S. Alsafwah, S. P. LaGuardia, M. Arroyo, B. K. Dockery, S. K. Bhattacharya, R. A. Ahokas, and K. P. Newman
Congestive Heart Failure is a Systemic Illness: A Role for Minerals and Micronutrients
Clin. Med. Res., December 1, 2007; 5(4): 238 - 243.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Thomas, A. Vidal, S. K. Bhattacharya, R. A. Ahokas, Y. Sun, I. C. Gerling, and K. T. Weber
Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2361 - H2366.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Wenxia Chai, Y. M Hoedemaekers, R. H. van Schaik, M. van Fessem, I. M Garrelds, J. J Saris, D. Dooijes, F. J ten Cate, M. M. Kofflard, and A. J. Danser
Cardiac aldosterone in subjects with hypertrophic cardiomyopathy
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 225 - 230.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
Y. Sun, R. A. Ahokas, S. K. Bhattacharya, I. C. Gerling, L. D. Carbone, and K. T. Weber
Oxidative stress in aldosteronism
Cardiovasc Res, July 15, 2006; 71(2): 300 - 309.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Vidal, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, I. C. Gerling, and K. T. Weber
Calcium paradox of aldosteronism and the role of the parathyroid glands
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H286 - H294.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
E. C. Miner and W. L. Miller
A Look Between the Cardiomyocytes: The Extracellular Matrix in Heart Failure
Mayo Clin. Proc., January 1, 2006; 81(1): 71 - 76.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Quinkler, D. Zehnder, K. S. Eardley, J. Lepenies, A. J. Howie, S. V. Hughes, P. Cockwell, M. Hewison, and P. M. Stewart
Increased Expression of Mineralocorticoid Effector Mechanisms in Kidney Biopsies of Patients With Heavy Proteinuria
Circulation, September 6, 2005; 112(10): 1435 - 1443.
[Abstract] [Full Text] [PDF]